Global Pediatric Clinical Trials Market Size is Estimated to Reach USD 22.69 billion by 2030, Growing at a CAGR of 5.24 %: Straits Research
06 mars 2024 10h05 HE
|
Reed Intelligence
New York, United States, March 06, 2024 (GLOBE NEWSWIRE) -- For many pediatric indications, only pediatric clinical trials can approve novel medications. Pharmaceutical and biotechnology businesses...
[Latest] Global Activated Carbon Market Size/Share Worth USD 9.4 Billion by 2032 at a 5.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
26 févr. 2024 12h30 HE
|
Custom Market Insights
Austin, TX, USA, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Activated Carbon Market Size, Trends and Insights By Type (Powdered Activated...
Charting New Paths: Non-TNF's Evolving in Rheumatoid Arthritis Market
23 févr. 2024 13h50 HE
|
Spherix Global Insights
EXTON, PA, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Amidst the array of advanced treatment avenues available for rheumatoid arthritis (RA), ranging from legacy TNF inhibitors and their newer biosimilar...
NATIONALLY RANKED ROSEN LAW FIRM Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation – ALT
19 févr. 2024 16h53 HE
|
The Rosen Law Firm PA
NEW YORK, Feb. 19, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Altimmune,...
[Latest] Global Crop Protection Chemicals Market Size/Share Worth USD 98.5 Billion by 2032 at a 4.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
13 févr. 2024 11h30 HE
|
Custom Market Insights
Austin, TX, USA, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Crop Protection Chemicals Market Size, Trends and Insights By Type (Herbicides,...
Palisade Bio Provides Corporate Update and Reiterates Guidance
13 févr. 2024 08h35 HE
|
Palisade Bio, Inc.
– Company announces strategic streamlining of Board to align with the current state of clinical development and corporate vision – Advancement of PALI-2108 for the treatment of moderate-to-severe...
Autonomix Medical, Inc. to Ring the Nasdaq Stock Market Closing Bell on Thursday, February 1, 2024
31 janv. 2024 08h45 HE
|
Autonomix Medical, Inc.
THE WOODLANDS, TX., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to...
Vascular access device Market Size Worth USD 10.90 Billion in 2032 | Emergen Research
29 janv. 2024 11h00 HE
|
Emergen Research
Vancouver, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The global vascular access device market size was USD 5.45 Billion in 2022 and is expected to register a rapid revenue CAGR of 7.1% during the forecast...
GRI Bio Announces Reverse Stock Split
26 janv. 2024 08h05 HE
|
GRI Bio, Inc.
GRI’s common stock is expected to begin trading on a post-split adjusted basis on January 30, 2024 LA JOLLA, CA, Jan. 26, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the...
Osteoporosis Drugs Market Size Worth USD 20.53 Billion in 2032 | Emergen Research
18 janv. 2024 10h15 HE
|
Emergen Research
Vancouver, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The global osteoporosis drugs market size was USD 13.06 billion in 2022 and is expected to register a revenue CAGR of 4.7% during the forecast period....